Skip to main content
Equibles

STATE STREET CORP

Position in LPCN — Lipocine Inc.

CIK 93751 BOSTON, MA
Back to LPCN Full portfolio

Position in LPCN

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$57,361
-$121,670 QoQ
Shares Held
22,407
0.0% QoQ
Ownership
0.272%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 36 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 76% Shared 0% None 24%

Common Shares in LPCN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. LPCN ranks #377 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in LPCN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $57,361 22,407
2026-03-31 $179,031 22,407
2025-12-31 $149,566 18,626
2025-09-30 $53,084 18,626
2025-06-30 $58,858 18,626
2025-03-31 $59,230 18,626
2024-12-31 $90,894 18,626
2024-09-30 $83,630 18,626
2024-06-30 $153,478 18,626
2024-03-31 $96,855 18,626
2023-12-31 $51,966 18,626
2023-09-30 $55,505 18,626
2023-06-30 $93,875 18,626
2023-03-31 $100,689 316,633
2022-12-31 $126,019 316,633
2022-09-30 $142,484 316,633
2022-06-30 $253,623 316,633
2022-03-31 $448,544 327,405
2021-12-31 $301,875 304,617
2021-09-30 $332,032 304,617
2021-06-30 $426,463 304,617
2021-03-31 $18,724 12,400
2020-12-31 $16,864 12,400
2020-09-30 $17,484 12,400
2020-06-30 $15,624 12,400
2020-03-31 $5,952 12,400